← Leaderboards
Sarah Nicole Statt
Asuragen, Inc.
$1,440,948
Attributed
$1,440,948
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $984.8K · FY2017–19$1M$750K$500K$250K$0
'17
'18
'19
Funding mix
By agency
NIH$1,440,948 · 4
By mechanism
R44$759,812 · 1
R43$681,136 · 3
Top collaborators
No co-investigators on record.
Most similar at Asuragen, Inc.
Same institution · by research overlap
- Eran Bram$619,938
- Jessica Lynn Larson$494,216
Others in their field
Other Emerging Leaders on “Sampling”
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$181,167,581
- Beth Baseler · Leidos Biomedical Research, Inc.$105,136,677
- Scott Topper · Broad Institute, Inc.$77,958,806
- Paul F Gallagher · Woods Hole Oceanographic Institution$63,916,876
- Leonard Freedman · Leidos Biomedical Research, Inc.$60,323,945
- Dale Sandler · Social And Scientific Systems, Inc.$59,740,435
Research focus
SamplingComputer SoftwarePerformanceCell LineBaseGenesGenotypeScreeningFoundationsStretchingDiagnosticDiagnosisFmr1MutationLinkPerformance TestsGeneticGenomic DnaAlzheimer&AposLengthResolutionClinical ResearchDetectionSuccess
Grant awards (4)
Novel Strategies for Enhanced Detection of Hemoglobinopathy Carriers$231,153
R43 · FY2019 · HL · contact PI
Novel strategies for enhanced analysis of repeat disorders$224,999
R43 · FY2018 · HD · contact PI
Development of an information-rich assay for C9ORF72 as a test for ALS and FTD$759,812
R44 · FY2017 · NS · contact PI
Development of a unified Alzheimer's disease test that combines high resolution analysis of TOMM40 and Apolipoprotein E for improved risk estimates$224,984
R43 · FY2017 · AG · contact PI